Glaxo Seretide Preventative Claim Judged Misleading By PMCPA
Executive Summary
A preventative asthma claim in a Glaxo Wellcome promotional piece for the fluticasone/salmeterol combination therapy Seretide has been judged to be "misleading and not capable of substantiation" by the U.K.' s Prescription Medicines Code of Practice Authority.